// App-Quantinova.ai

558 : Outcomes of second targeted therapy in metastatic renal carcinoma: A retrospective chart review in the EU.

Researchers

Presenter

  • Daniel Yick Chin Heng

Principal Investigators

  • Jinhee Park

  • James E. Signorovitch

  • Hongbo Yang

  • Jinlin Song

  • Dony Patel

  • Chinjune Lin

  • Thomas Powles

Medical Centers

  • Tom Baker Cancer Center - University of Calgary, Calgary, AB, Canada

  • Novartis Pharmaceutical Corporation, East Hanover, NJ

  • Analysis Group, Inc., Boston, MA

  • Navigant, London, United Kingdom

  • Barts Cancer Institute, Barts Health, and The Royal Free London NHS Foundation Trust, London, United Kingdom

Locations

  • Canada

  • United States

  • United Kingdom

Companies

  • Analysis Group, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • Renal cell carcinoma

  • Metastatic Renal Cell Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Pazopanib

  • Sunitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved